ArticleThe journal of nutrition, health & aging2009
Carla Task Force on Sarcopenia: propositions for clinical trials.
Article in The journal of nutrition, health & aging, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015Trial
- The impact of sarcopenia on a physical activity intervention: the Lifestyle Interventions and Independence for Elders Pilot Study (LIFE-P).The journal of nutrition, health & aging · 2014Trial
- Effects of whey proteins and carbohydrates on the efficacy of resistance training in elderly people: double blind, randomised controlled trial.European journal of clinical nutrition · 2013Trial
- The MUnich SArcopenia Registry (MUSAR) : Paving the way for increased visibility, more frequent diagnoses and innovative new treatment.Zeitschrift fur Gerontologie und Geriatrie · 2025Article
- Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions.Cells · 2022Review
- Critical appraisal of papers reporting recommendation on sarcopenia using the AGREE II tool: a EuroAIM initiative.European journal of clinical nutrition · 2020Article
- Selecting Potential Pharmacological Interventions in Sarcopenia.Drugs & aging · 2017Review
- The energy intake through regular nontherapeutic meals provision in long-term care: impact on nutritional status and related Geriatric Nutritional Risk Index.SpringerPlus · 2016Article
- Evaluation and Management of the Geriatric Urologic Oncology Patient.Current geriatrics reports · 2015Article
- Strength and function response to clinical interventions of older women categorized by weakness and low lean mass using classifications from the Foundation for the National Institute of Health sarcopenia project.The journals of gerontology. Series A, Biological sciences and medical sciences · 2015Article
- Vitamin D Deficiency Treatment Patterns in Academic Urban Medical Center.The American journal of pharmacy benefits · 2014Article
- Sarcopenia: biomarkers and imaging (International Conference on Sarcopenia research).The journal of nutrition, health & aging · 2011Article
- Pro-dromal sarcopenia.The journal of nutrition, health & aging · 2011Article
- Clinical trials on sarcopenia: methodological issues regarding phase 3 trials.Clinics in geriatric medicine · 2011Review
- Designing Phase II B trials in sarcopenia: the best target population.The journal of nutrition, health & aging · 2011Article
- Frailty: diagnosis and management.The journal of nutrition, health & aging · 2011Article
- Is the Mini Nutritional Assessment an appropriate tool to assess frailty in older adults?The journal of nutrition, health & aging · 2011Article
- Clinical practice in nursing homes as a key for progress.The journal of nutrition, health & aging · 2010Article
- Nutritional recommendations for the management of sarcopenia.Journal of the American Medical Directors Association · 2010Review
- Functional consequences of sarcopenia and dynapenia in the elderly.Current opinion in clinical nutrition and metabolic care · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
In the presence of an aging population, public health priorities need to evolve. As the populations gets older, the already existing pathologies have become commonplace with specific geriatric clinical syndromes like frailty, mobility disability, or cognitive impairment, among others. Sarcopenia is a good example for which geriatricians, neurologists, physiologists, nutritionists and epidemiologists need to find a consensual definition and diagnostic tool as well as guidelines for the management of clinical trials and possible treatments. The Carla Sarcopenia Task Force, which met in the south of France (Toulouse) for an expert consensus meeting called "Les Entretiens du Carla", have addressed a series of existing issues to place Sarcopenia into a nosological context: a definition which should be a composite of a change in muscle mass and a change in strength/function depending on either a progressive and chronic wasting process or an acute onset of loss of muscle mass; a recommendation for DXA and the Short Physical Performance Battery as a clinical pragmatic approach of Sarcopenia; a differentiated approach for clinical studies according to prevention or treatment objectives and depending on the sub-groups and target populations; and finally, a summary of therapeutic strategies currently recommended. The aim of "Les Entretiens du Carla", based on an expert meeting panel, was to address a series of unsolved issues in the field of Sarcopenia by combining the expert opinion with a revision of the existing literature on the topic. Through this report, the reader will appreciate the determination to find conclusions on the various issues and further studies to be developed to determine the best multidisciplinary approach needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.